{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T11:17:30Z","timestamp":1788866250452,"version":"build-2803163510"},"reference-count":13,"publisher":"SAGE Publications","issue":"4","license":[{"start":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T00:00:00Z","timestamp":1756339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Endovasc Ther"],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Acute limb ischemia (ALI) is a serious condition leading to amputation and mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients and Methods:<\/jats:title>\n                    <jats:p>\n                      This prospective randomized study included 50 patients with thrombotic ALI treated at 2 hospitals between September 1, 2021, and August 31, 2023. Patients were randomly assigned using a double-blind method into Group A (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      \u2009=\u200925), treated with percutaneous mechanical thrombectomy (PMT), and Group B (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      \u2009=\u200925), receiving catheter-directed thrombolysis (CDT).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      The mean age was 67.16\u2009\u00b1\u20099.56\u2009years in Group A and 56.88\u2009\u00b1\u200911.38\u2009years in Group B (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009=\u2009.001), though gender distribution was comparable. Diabetes mellitus (DM) was the most prevalent risk factor (88% in Group A, 72% in Group B), followed by hypertension (68%) in Group A and smoking (56%) in Group B, with no significant differences between groups. Superficial femoral artery and popliteal artery occlusions were the most common findings (68% and 56% in Group A, 72% and 68% in Group B). Retrograde contralateral femoral access was used in 60% of Group A and 56% of Group B. The technical success rate showed a tendency to be higher but did not reach statistical significance in Group A (96%) than in Group B (80%). Perioperative complications occurred in 8% of patients in both groups, with Group A experiencing 1 vessel perforation and 1 distal embolization, while Group B had 1 intracranial hemorrhage and 1 pseudoaneurysm. The 30-day mortality rate was 0% in Group A and 8% in Group B (not statistically significant). Primary patency rates at 1\u2009month were 84.0% in Group A and 81% in Group B, decreasing to 62.5% and 55.6% at 1\u2009year, respectively. Group A had 1 below-knee amputation and no above-knee amputations, whereas Group B had 2 below-knee and 3 above-knee amputations.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>PMT appeared to have a tendency toward higher technical success and lower amputation rates, with a safety profile similar to CDT, though these differences were not statistically significant. Its single-session approach and potential for reduced bleeding risk might offer some advantages, while CDT generally requires prolonged infusion.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical Impact<\/jats:title>\n                    <jats:p>This randomized study suggests that percutaneous mechanical thrombectomy (PMT) using the Rotarex\u00ae\ufe0f device may offer advantages over catheter-directed thrombolysis (CDT) in selected patients with acute thrombotic lower limb ischemia without motor deficit. PMT achieved rapid revascularization in a single session with a tendency toward higher technical success and fewer amputations, while maintaining a safety profile comparable to CDT. By potentially reducing treatment time, bleeding risk, and the need for intensive monitoring, PMT could represent a valuable addition to current endovascular practice. Larger multicenter studies with longer follow-up are warranted to confirm these findings and guide future clinical adoption.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/15266028251363509","type":"journal-article","created":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T13:34:36Z","timestamp":1756388076000},"page":"2129-2138","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":2,"title":["Randomized Prospective Comparative Study of Mechanical Thrombectomy by Rotarex\u00ae Device Versus Catheter-Directed Thrombolysis in the Management of Acute Thrombotic Lower Limb Ischemia Without Motor Deficit"],"prefix":"10.1177","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-0929-6809","authenticated-orcid":false,"given":"Sherif O.","family":"Elkerdawi","sequence":"first","affiliation":[{"name":"Vascular Surgery Department, Faculty of Medicine, Helwan University, Helwan, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mostafa S.","family":"Abdelbary","sequence":"additional","affiliation":[{"name":"Vascular Surgery Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed A.","family":"Rizk","sequence":"additional","affiliation":[{"name":"Vascular Surgery Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossameldin","family":"Ibrahim","sequence":"additional","affiliation":[{"name":"Vascular Surgery Department, Faculty of Medicine, Helwan University, Helwan, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karim","family":"El-Awady","sequence":"additional","affiliation":[{"name":"Vascular Surgery Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,8,28]]},"reference":[{"key":"e_1_3_2_2_2","first-page":"54","article-title":"Percutaneous thrombectomy or ultrasound-accelerated thrombolysis for initial management of acute limb ischaemia","volume":"1","author":"Araujo ST","year":"2022","unstructured":"Araujo ST, Moreno DH, Cacione DG. Percutaneous thrombectomy or ultrasound-accelerated thrombolysis for initial management of acute limb ischaemia. Cochrane Database Syst Rev. 2022;1:54-69.","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2018.07.056"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/2362769"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00270-011-0258-z"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S131503"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1177\/1526602815592849"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2019.03.081"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2020.557420"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1186\/s42155-018-0041-1"},{"issue":"3","key":"e_1_3_2_11_2","first-page":"86","article-title":"Effects of intravenous and catheter directed thrombolytic therapy with recombinant tissue plasminogen activator (Alteplase) in non-traumatic acute limb ischemia: a randomized double-blind clinical trial","volume":"3","author":"Saroukhani A","year":"2015","unstructured":"Saroukhani A, Ravari H, Pezeshki Rad M. Effects of intravenous and catheter directed thrombolytic therapy with recombinant tissue plasminogen activator (Alteplase) in non-traumatic acute limb ischemia: a randomized double-blind clinical trial. Bull Emerg Trauma. 2015;3(3):86-92.","journal-title":"Bull Emerg Trauma"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1024\/0301-1526\/a000495"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2019.05.031"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2002-35942"}],"container-title":["Journal of Endovascular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/15266028251363509","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/15266028251363509","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/15266028251363509","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T10:55:27Z","timestamp":1784199327000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/15266028251363509"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,28]]},"references-count":13,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["10.1177\/15266028251363509"],"URL":"https:\/\/doi.org\/10.1177\/15266028251363509","relation":{},"ISSN":["1526-6028","1545-1550"],"issn-type":[{"value":"1526-6028","type":"print"},{"value":"1545-1550","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,28]]}}}